HomeBUSINESS
BUSINESS

Mitsubishi Tanabe Grabs Distribution Rights to Clenafin/Jublia in Taiwan
(Nov.9.2017)

Kaken Pharmaceutical has granted exclusive distribution rights in Taiwan to Mitsubishi Tanabe Pharma’s local subsidiary for its topical onychomycosis drug efinaconazole, known as Clenafin in Japan and Jublia overseas, the two companies said on November 8 ...
(LOG IN FOR FULL STORY)

News Calendar